Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Hakimi, Zalmaï; Herdman, Mike; Pavesi, Marco; Devlin, Nancy; Nazir, Jameel; Hoyle, Christopher; Odeyemi, Isaac

doi:10.1007/s11136-016-1460-x

Cited by 5 publications

(5 citation statements)

References 29 publications

Supporting

Mentioning

Contrasting

Order By: Relevance

“…1,2 By obstructing urinary flow, BPH frequently causes lower urinary tract symptoms (LUTS), which are a significant burden in ageing men, and have a major negative impact on quality of life (QoL); it also increases the risk of disease progression. 1,[3][4][5][6][7] Although BPH is the most common cause of LUTS, other possible causes exist; therefore, comprehensive assessment facilitating an accurate diagnosis of BPH as a cause of LUTS is crucial. [8][9][10][11] As per clinical guidelines in Spain, the following assessments are mandatory: clinical history, physical exam, digital rectal exam (DRE) and urinalysis; and the following assessments are recommended: prostate-specific antigen (PSA) and International Prostate Symptom Score (IPSS).…”

Section: Introductionmentioning

confidence: 99%

“…Benign prostatic hyperplasia (BPH) is a progressive, non‐malignant overgrowth of the prostate gland commonly observed in men over 50 years of age 1,2 . By obstructing urinary flow, BPH frequently causes lower urinary tract symptoms (LUTS), which are a significant burden in ageing men, and have a major negative impact on quality of life (QoL); it also increases the risk of disease progression 1,3‐7 …”

Section: Introductionmentioning

confidence: 99%

See 1 more Smart Citation

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

Molero

Miñana

Palacios‐Moreno

et al. 2020

Int. J. Clin. Pract.

View full text Add to dashboard Cite

show abstract

Section: Introductionmentioning

confidence: 99%

Section: Introductionmentioning

confidence: 99%

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

Molero

Miñana

Palacios‐Moreno

et al. 2020

Int. J. Clin. Pract.

View full text Add to dashboard Cite

show abstract

“…An estimated 50% of men have pathological signs of BPH in the 51-60 age group, a proportion that increases to more than 70% among men in the 61-70 age group. The enlarged prostate might cause bothersome LUTS, requiring treatment with medication or surgery or both (Hakimi et al, 2017). The results of self-care agency in this study showed that the mean ESCA scale score of elderly patients with BPH was 110.01 and that 58.6% of the participants were at the middle level with regard to self-care agency.…”

Section: Discussionmentioning

confidence: 57%

Self-Care and Quality of Life in Elderly Chinese Patients with Benign Prostatic Hyperplasia

Tong

Xie

2019

Nurs Sci Q

View full text Add to dashboard Cite

The authors in this study explored the relationship between self-care agency and quality of life in patients with benign prostatic hyperplasia. A convenience sample of 157 patients was interviewed. The levels of both self-care agency and quality of life were close to the mean. Pearson correlation analysis demonstrated that quality of life was positively correlated with self-care agency and the self-care subgroups of abilities, responsibility, esteem, and evaluation. Improved self-care agency and the four subscale items could enhance quality of life. Intervention programs for benign prostatic hyperplasia patients must emphasize self-care agency so as to improve their health behavior and quality of life.

show abstract

“…PCHC has been employed in other studies to document change over time in various diseases, such as heart failure, prostate cancer, diabetes mellitus and overactive bladder. [44][45][46][47][48] The change for the fracture patients cannot be compared directly to changes for other patient groups due to the recall technique used to value health state before injury.…”

Section: Comparisons With Other Studiesmentioning

confidence: 99%

Longitudinal study of patients’ health-related quality of life using EQ-5D-3L in 11 Swedish National Quality Registers

et al. 2022

Self Cite

View full text Add to dashboard Cite

ObjectiveTo compare problems reported in the five EQ-5D-3L dimensions and EQ VAS scores at baseline and at 1-year follow-up among different patient groups and specific diagnoses in 11 National Quality Registers (NQRs) and to compare these with the general population.DesignLongitudinal, descriptive study.Participants2 66 241 patients from 11 NQRs and 49 169 participants from the general population were included in the study.Primary and secondary outcome measuresProportions of problems reported in the five EQ-5D-3L dimensions, EQ VAS scores of participants’ own health and proportions of participants and mean/median EQ VAS score in the Paretian Classification of Health Change (PCHC) categories.ResultsIn most of the included registers, and the general population, problems with pain/discomfort were the most frequently reported at baseline and at 1-year follow-up. Mean EQ VAS score (SD) ranged from 45.2 (22.4) among disc hernia patients to 88.1 (15.3) in wrist and hand fracture patients at baseline. They ranged from 48.9 (20.9) in pulmonary fibrosis patients to 83.3 (17.4) in wrist and hand fracture patients at follow-up. The improved category of PCHC, improvement in at least one dimension without deterioration in any other, accounted for the highest proportion in several diagnoses, corresponding with highest improvement in mean EQ VAS score.ConclusionsThe study documented self-reported health of several different patient groups using the EQ-5D-3L in comparing with the general population. This demonstrated the important role of patient-reported outcomes in routine clinical care, to assess and follow-up health status and progress within different groups of patients. The EQ-5D-3L descriptive system and EQ VAS have an important role in providing a ‘common denominator’, allowing comparisons across NQRs and specific diagnoses.Trial registration numberClinicalTrials.gov (NCT04359628).

show abstract

Using EQ-5D-3L and OAB-5D to assess changes in the health-related quality of life of men with lower urinary tract symptoms associated with benign prostatic hyperplasia

Abstract: A large ceiling effect on EQ-5D-3L substantially limited its sensitivity in this population. OAB-5D proved more sensitive to changes in health status and could be considered a complement to ED-5D-3L as a source of utilities for health economic modelling.

Cited by 5 publications

References 29 publications

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

Real‐world assessment and characteristics of men with benign prostatic hyperplasia (BPH) in primary care and urology clinics in Spain

Self-Care and Quality of Life in Elderly Chinese Patients with Benign Prostatic Hyperplasia

Longitudinal study of patients’ health-related quality of life using EQ-5D-3L in 11 Swedish National Quality Registers

Contact Info

Product

Resources

About